{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:40:59Z","timestamp":1768084859889,"version":"3.49.0"},"reference-count":25,"publisher":"Zhejiang University Press","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1631\/jzus.b1200021","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T16:51:02Z","timestamp":1352307062000},"page":"867-874","source":"Crossref","is-referenced-by-count":20,"title":["Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl\/\u03b2-catenin axis"],"prefix":"10.1631","volume":"13","author":[{"given":"Xiao-hua","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-chao","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen-bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-fen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2012,11,8]]},"reference":[{"issue":"24","key":"3311_CR1","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4161\/cc.5.24.3573","volume":"5","author":"D.J. Barnes","year":"2006","unstructured":"Barnes, D.J., Melo, J.V., 2006. Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle, 5(24):2862\u20132866. [doi:10.4161\/cc.5.24.3573]","journal-title":"Cell Cycle"},{"issue":"7","key":"3311_CR2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2174\/187152010793498609","volume":"10","author":"Y. Chen","year":"2010","unstructured":"Chen, Y., Tseng, S.H., 2010. The potential of tetrandrine against gliomas. Anticancer Agents Med. Chem., 10(7): 534\u2013542. [doi:10.2174\/187152010793498609]","journal-title":"Anticancer Agents Med. Chem."},{"issue":"7","key":"3311_CR3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y. Chen","year":"2009","unstructured":"Chen, Y., Hu, Y., Zhang, H., Peng, C., Li, S., 2009a. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat. Genet., 41(7):783\u2013792. [doi:10.1038\/ng.389]","journal-title":"Nat. Genet."},{"issue":"8","key":"3311_CR4","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/leu.2009.52","volume":"23","author":"Y. Chen","year":"2009","unstructured":"Chen, Y., Hu, Y., Michaels, S., Segal, D., Brown, D., Li, S., 2009b. Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice. Leukemia, 23(8):1446\u20131454. [doi:10.1038\/leu.2009.52]","journal-title":"Leukemia"},{"issue":"5","key":"3311_CR5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601485","volume":"26","author":"A.M. Coluccia","year":"2007","unstructured":"Coluccia, A.M., Vacca, A., Du\u00f1ach, M., Mologni, L., Redaelli, S., Bustos, V.H., Benati, D., Pinna, L.A., Gambacorti-Passerini, C., 2007. Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO J., 26(5):1456\u20131466. [doi:10.1038\/sj. emboj.7601485]","journal-title":"EMBO J."},{"issue":"3","key":"3311_CR6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C. Dierks","year":"2008","unstructured":"Dierks, C., Beigi, R., Guo, G.R., Zirlik, K., Stegert, M.R., Manley, P., Trussell, C., Schmitt-Graeff, A., Landwerlin, K., Veelken, H., et al., 2008. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell, 14(3):238\u2013249. [doi:10.1016\/j.ccr.2008.08.003]","journal-title":"Cancer Cell"},{"issue":"5","key":"3311_CR7","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood-2004-08-3373","volume":"105","author":"L.J. Elrick","year":"2005","unstructured":"Elrick, L.J., Jorgensen, H.G., Mountford, J.C., Holyoake, T.L., 2005. Punish the parent not the progeny. Blood, 105(5):1862\u20131866. [doi:10.1182\/blood-2004-08-3373]","journal-title":"Blood"},{"issue":"11","key":"3311_CR8","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","volume":"105","author":"M.L. Guzman","year":"2005","unstructured":"Guzman, M.L., Rossi, R.M., Karnischky, L., Li, X., Peterson, D.R., Howard, D.S., Jordan, C.T., 2005. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood, 105(11):4163\u20134169. [doi:10.1182\/blood-2004-10-4135]","journal-title":"Blood"},{"issue":"2","key":"3311_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1124\/mol.110.068668","volume":"79","author":"B.C. He","year":"2011","unstructured":"He, B.C., Gao, J.L., Zhang, B.Q., Luo, Q., Shi, Q., Kim, S.H., Huang, E., Gao, Y., Yang, K., Wagner, E.R., et al., 2011. Tetrandrine inhibits Wnt\/\u03b2-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol. Pharmacol., 79(2):211\u2013219. [doi:10.1124\/mol.110.068668]","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"3311_CR10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.leu.2403724","volume":"19","author":"M.S. Holtz","year":"2005","unstructured":"Holtz, M.S., Forman, S.J., Bhatia, R., 2005. Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia, 19(6):1034\u20131041. [doi:10.1038\/sj.leu.2403724]","journal-title":"Leukemia"},{"issue":"6","key":"3311_CR11","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","volume":"94","author":"T. Holyoake","year":"1999","unstructured":"Holyoake, T., Jiang, X., Eaves, C., Eaves, A., 1999. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood, 94(6): 2056\u20132064.","journal-title":"Blood"},{"issue":"1","key":"3311_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","volume":"23","author":"Y. Hu","year":"2009","unstructured":"Hu, Y., Chen, Y., Douglas, L., Li, S., 2009. \u03b2-Catenin is essential for survival of leukemia stem cells in sensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia, 23(1):109\u2013116. [doi:10.1038\/leu.2008.262]","journal-title":"Leukemia"},{"issue":"4","key":"3311_CR13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.leu.2405086","volume":"22","author":"H. Konig","year":"2008","unstructured":"Konig, H., Holtz, M., Modi, H., Manley, P., Holyoake, T.L., Forman, S.J., Bhatia, R., 2008. Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia, 22(4): 748\u2013755. [doi:10.1038\/sj.leu.2405086]","journal-title":"Leukemia"},{"issue":"10","key":"3311_CR14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","volume":"12","author":"D.S. Krause","year":"2006","unstructured":"Krause, D.S., Lazarides, K., von Andrian, U.H., van Etten, R.A., 2006. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat. Med., 12(10):1175\u20131180. [doi:10.1038\/nm1489]","journal-title":"Nat. Med."},{"issue":"12","key":"3311_CR15","first-page":"1093","volume":"23","author":"J.H. Lai","year":"2002","unstructured":"Lai, J.H., 2002. Immunomodulatory effects and mechanisms of plant alkaloid tetrandrine in autoimmune diseases. Acta Pharmacol. Sin., 23(12):1093\u20131101.","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"3311_CR16","first-page":"1239","volume":"21","author":"J.H. Lee","year":"2002","unstructured":"Lee, J.H., Kang, G.H., Kim, K.C., Kim, K.M., Park, D.I., Choi, B.T., Kang, H.S., Lee, Y.T., Choi, Y.H., 2002. Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Int. J. Oncol., 21(6):1239\u20131244.","journal-title":"Int. J. Oncol."},{"issue":"6","key":"3311_CR17","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1582-4934.2007.00108.x","volume":"11","author":"S. Li","year":"2007","unstructured":"Li, S., Li, D., 2007. Stem cell and kinase activity-independent pathway in resistance of leukaemia to BCR-ABL kinase inhibitors. J. Cell. Mol. Med., 11(6):1251\u20131262. [doi:10. 1111\/j.1582-4934.2007.00108.x.]","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"3311_CR18","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.25817","volume":"129","author":"C. Liu","year":"2011","unstructured":"Liu, C., Gong, K., Mao, X., Li, W., 2011. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int. J. Cancer, 129(6):1519\u20131531. [doi:10.1002\/ijc.25817]","journal-title":"Int. J. Cancer"},{"issue":"4","key":"3311_CR19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/leu.2008.27","volume":"22","author":"J.A. McCubrey","year":"2008","unstructured":"McCubrey, J.A., Steelman, L.S., Abrams, S.L., Bertrand, F.E., Ludwig, D.E., B\u00e4secke, J., Libra, M., Stivala, F., Milella, M., Tafuri, A., Lunghi, P., et al., 2008. Targeting survival cascades induced by activation of Ras\/Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways for effective leukemia therapy. Leukemia, 22(4):708\u2013722. [doi:10.1038\/leu.2008.27]","journal-title":"Leukemia"},{"issue":"24","key":"3311_CR20","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1158\/0008-5472.CAN-04-0313","volume":"64","author":"L.H. Meng","year":"2004","unstructured":"Meng, L.H., Zhang, H., Hayward, L., Takemura, H., Shao, R.G., Pommier, Y., 2004. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res., 64(24):9086\u20139092. [doi:10.1158\/0008-5472.CAN-04-0313]","journal-title":"Cancer Res."},{"issue":"1","key":"3311_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1142\/S0192415X06003692","volume":"34","author":"L.T. Ng","year":"2006","unstructured":"Ng, L.T., Chiang, L.C., Lin, Y.T., Lin, C.C., 2006. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. Am. J. Chin. Med., 34(1): 125\u2013135. [doi:10.1142\/s0192415x06003692]","journal-title":"Am. J. Chin. Med."},{"issue":"9","key":"3311_CR22","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4161\/cc.8.9.8209","volume":"8","author":"S.A. Stuart","year":"2009","unstructured":"Stuart, S.A., Minami, Y., Wang, J.Y., 2009. The CML stem cell: evolution of the progenitor. Cell Cycle, 8(9):1338\u20131343. [doi:10.4161\/cc.8.9.8209]","journal-title":"Cell Cycle"},{"issue":"10","key":"3311_CR23","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1248\/bpb.28.1979","volume":"28","author":"F.P. Wang","year":"2005","unstructured":"Wang, F.P., Wang, L., Yang, J.S., Nomura, M., Miyamoto, K., 2005. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells. Biol. Pharm. Bull., 28(10):1979\u20131982. [doi:10.1248\/bpb.28.1979]","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"3311_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.leukres.2005.05.023","volume":"30","author":"R. Xu","year":"2006","unstructured":"Xu, R., Dong, Q., Yu, Y., Zhao, X., Gan, X., Wu, D., Lu, Q., Xu, X., Yu, X.F., 2006. Berbamine: a novel inhibitor of bcr\/abl fusion gene with potent anti-leukemia activity. Leuk. Res., 30(1):17\u201323. [doi:10.1016\/j.leukres.2005. 05.023]","journal-title":"Leuk. Res."},{"issue":"1","key":"3311_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2011.01.022","volume":"304","author":"Y. Zhang","year":"2011","unstructured":"Zhang, Y., Wang, C., Wang, H., Wang, K., Du, Y., Zhang, J., 2011. Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo. Cancer Lett., 304(1):21\u201332. [doi:10.1016\/j.canlet.2011.01.022]","journal-title":"Cancer Lett."}],"container-title":["Journal of Zhejiang University SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1200021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1200021\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1200021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T18:46:22Z","timestamp":1594838782000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1200021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["3311"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1200021","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}